Prior Art That Was Considered but Not Relied Upon by an Expert is Fair Game for Discovery in IPRs

Dec 20, 2019

Reading Time : 2 min

Petitioner Adobe Inc. initiated IPR proceedings against Patent Owner RAH Color Technologies LLC over four patents claiming a “system for distributing and controlling color reproduction at multiple sites.”  On October 24, 2019, Patent Owner deposed Petitioner’s expert and asked three questions about the expert’s review of prior art: (1) whether the expert performed any prior art search, (2) whether the expert considered claim charts comparing the patents at issue to the prior art and (3) whether the expert determined that any prior art references rendered the patents at issue obvious. Petitioner instructed its expert not to answer these questions, invoking attorney work product protections and Rule 26 of the Federal Rules of Civil Procedure. On October 25, after a telephonic conference with the parties, the three-judge PTAB panel authorized the parties to submit briefing on the issue.

In support of its motion to compel testimony, Patent Owner argued that facts and data underlying an expert opinion are not only relevant to IPR proceedings, but necessary to assess the expert’s independence, reliability and credibility. Patent Owner further argued that Rule 26 does not apply to IPR proceedings, but even if it did, the rule would, nonetheless, compel disclosure of the facts and data that an expert considered. The Board agreed that the Patent Owner’s questions concerned underlying factual bases, not attorney communications or the content of prior art, and thus were within the scope of permissible discovery. The panel also credited the argument that Rule 26 would compel disclosure of underlying facts and data, even if the Federal Rules applied to IPR proceedings.     

Turning to Petitioner’s assertions, the PTAB rejected the argument that prior art on which the Board had not instituted review was outside the scope of discovery. On the contrary, according to the Board, if expert testimony is to be given any weight, a party must disclose all art considered and reviewed in preparation of the testimony. The Board also disagreed that Patent Owner’s line of questioning would reveal the analysis and strategy of Petitioner’s attorneys, because Patent Owner asked for only the identities of the documents that Petitioner’s expert reviewed. The Board distinguished this inquiry from questions about attorney communications and suggestions for editing and drafting an expert opinion.

The PTAB ultimately granted Patent Owner’s motion, but—in the interest of efficiency—treated the questions as interrogatories and ordered Petitioner’s expert to provide certified written responses to be filed within a week of the order.

Practice tip

Though the scope of allowable discovery is more limited for IPR proceedings than for district court litigation, a party to an IPR may seek and obtain discovery related to the underlying facts and data informing the opinion of an opposing party’s expert. This includes prior art considered, but not relied upon by the expert in forming his or her opinions.

Adobe Inc. v. RAH Color Technologies LLC, IPR2019-00627, IPR2019-00628, IPR2019-00629, IPR2019-00646 (PTAB December 12, 2019)

Share This Insight

Previous Entries

IP Newsflash

November 11, 2025

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board’s unpatentability findings regarding other claims in the same patent. In doing so, the Federal Circuit reiterated that issue preclusion does not apply where the prior factual determinations were made under a lower standard of proof.

...

Read More

IP Newsflash

November 3, 2025

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

...

Read More

IP Newsflash

October 31, 2025

The District Court for the Northern District of California recently granted a defendant’s motion to bifurcate, ordering that issues related to PGR estoppel should be decided in a bench trial, while the remaining issues in the case should proceed to a jury trial.

...

Read More

IP Newsflash

October 31, 2025

The Northern District of Iowa recently held that a defendant’s motion for partial summary judgment of invalidity was barred after the PTAB issued final written decisions, regardless of when the motion was filed. The defendant filed its motion before the final written decisions were issued, but the court rejected the defendant’s argument that the timing of the motion insulated it from estoppel.

...

Read More

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.